Results 21 to 30 of about 32,024 (272)
Medicines legislation and regulation in the United Kingdom 1500‐2020
British Journal of Clinical Pharmacology, Volume 89, Issue 1, Page 80-92, January 2023., 2023 The initial purposes of regulation of medicines in England, and latterly in the United Kingdom, were principally to raise government revenue, to discourage murder by poisoning and to regulate the activities of pharmacists. It was only much later that regulators sought to ensure that medicines were of good quality, reasonably safe, and at least somewhat
Robin E. Ferner, Jeffrey K. Aronson
wiley +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
, 2022 Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source
Basic &Clinical Pharmacology &Toxicology, Volume 132, Issue 1, Page 111-119, January 2023., 2023 Abstract Information regarding deaths caused by poisoning or adverse effects of medication in Danish persons not using illicit narcotic drugs (PNUIDs) is sparse. To characterize aetiology, demographics, and death scene, we reviewed all legal autopsies performed at Aarhus University from 2017 to 2019 and isolated 96 deaths caused by medications in ...
Charlotte U. Andersen +4 more
wiley +1 more source
Antigen-specific electrophoretic cell separation for immunological investigations [PDF]
, 1989 Preincubation of human blood lymphocytes with cell surface antigen specific antibodies under non-capping conditions reduces the electrophoretic mobility of the corresponding lymphocyte subpopulation.
Hannig, K. +2 more
core +1 more source
Biomolecules, 2020 Matrix metalloproteinase-9 is upregulated in inflammatory bowel disease. Barbiturate nitrate hybrid compounds have been designed to inhibit MMP secretion and enzyme activity.
Shane O’Sullivan +4 more
doaj +1 more source
Infrared and Thermal Analysis of Vanadyl(II) Barbiturate Complex [PDF]
, 2009 An usual method for the preparation of vanadyl(II) barbiturate complex was performed under the chemical reaction of vanadyl(II) sulfate with barbituric acid (H2L) and formulated as: [VO(HL)2].2H2O.
El-Megharbel, Samy M., Refat, Moamen S.
core +2 more sources
Barbiturat dan Obat Pelumpuh Otot: Masih Bermanfaat untuk Menangani Hipertensi Intrakranial?
Jurnal Neuroanestesi Indonesia, 2013 Hipertensi intrakranial dapat menyebabkan cedera otak sekunder dan meningkatkan morbiditas serta mortalitas. Untuk mempertahankan tekanan intrakranial agar senantiasa dalam batas normal, maka cairan serebrospinal dan darah mempunyai kemampuan untuk ...
M. Sofyan Harahap
doaj +1 more source
Barbiturate AEDS, EEG and Cognitive Performance
Pediatric Neurology Briefs, 1997 Neuropsychological performance and quantitative EEGs were studied in 11 epileptic children, aged 7 to 14 years, both during treatment and without phenobarbital and mephobarbital, and in comparison to 13 matched controls, at Tulane University Medical ...
J Gordon Millichap
doaj +1 more source
Barbiturate-related hospitalisations, drug treatment episodes, and deaths in Australia, 2000‒2018
, 2022 Objectives: To determine the characteristics and population rates of barbiturate-related hospitalisations, treatment episodes, and deaths in Australia, 2000–2018.
Campbell, G +4 more
core +1 more source
Acta Crystallographica Section E: Crystallographic Communications, 2015 The title molecular salt, C5H12NO+·C12H8N5O9− [common name: 4-methylmorpholin-4-ium 1,3-dimethyl-5-(2,4,6-trinitrophenyl)barbiturate], possesses noticeable anticonvulsant and hypnotic activity.
Jeganathan Gomathi +1 more
doaj +1 more source